Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

FDA share new trial guidelines to further cancer therapy development

March 2, 2022 Research and Development

The FDA has issued three recommendations to industry for clinical trials, to support US President Joe Biden’s relaunch of the …
News

93% accuracy in new Alzheimer’s test, according to international study

February 23, 2022 Research and Development

The Washington University School of Medicine in St Louis has developed a blood test for Alzheimer’s disease which has proved …
News

Extra blood test could help detect risk of death from heart attack

February 23, 2022 Research and Development

Researchers say that an extra blood test on suspected heart-attack patients could determine if they are at high risk of …
News

FDA places gene therapy trial on hold

February 23, 2022 Research and Development

Homology Medicines has shared that the FDA has placed its pheNIX gene therapy trial of HMI-102 in adults with phenylketonuria …
News

NICE recommends Albireo’s Bylvay (odevixibat) for all PFIC types

February 23, 2022 Research and Development

NICE has issued guidance that recommends Bylvay (odevixibat) for the treatment of all types of progressive familial intrahepatic cholestasis (PFIC) …
News

Invitae launches first CE-IVD cancer testing kits in Europe

February 16, 2022 Research and Development

Invitae, leading medical genetics company, announced the availability of FusionPlex Dx and LiquidPlex Dx in Europe.With this development, the company …
News

AstraZeneca COVID-19 vaccine’s short shelf life inhibits rollout to poor countries

February 16, 2022 Research and Development

According to officials and WHO documents, the short shelf life of the AstraZeneca COVID-19 vaccine is complicating the rollout to …
News

Scientists possibly cure HIV in first-time breakthrough for virus

February 16, 2022 Research and Development

An American research team appear to have cured HIV in a woman for the first time, making her the third …
News

Moderna launch Omicron-specific UK vaccine study

February 16, 2022 Research and Development

Around 3,000 British volunteers are being sought to take part in a new study for Moderna’s Omicron booster vaccine. The …
News

FDA investigate possible increased risk of death with lymphoma medicine

February 9, 2022 Research and Development

The FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). The administration is continuing …
News

SaNOtize breakthrough treatment 99% effective against COVID-19

February 9, 2022 Research and Development

SaNOtize and Glenmark Pharmaceuticals Limited have announced successful results of their Phase III clinical trials, as well as the approval …
News

Despite persistent need, J&J halts COVID-19 vaccine output

February 9, 2022 Research and Development

Johnson & Johnson has temporarily suspended production at a key plant manufacturing the COVID-19 vaccine. The easily administered vaccine is …
News

Novavax submits EUA to FDA for COVID-19 vaccine candidate

February 2, 2022 Research and Development

Maryland-based Novavax has announced it is submitting an EUA request to the FDA, for its COVID-19 vaccine candidate.Novavax initially planned …
News

Omicron subvariant BA.2 likely to have same severity as ‘original’, says WHO

February 2, 2022 Research and Development

The BA.2 form of the Omicron coronavirus variant is unlikely to be any more severe than the original BA.1 form, …
News

FDA approval of six-annual-dose HIV treatment

February 2, 2022 Research and Development

ViiV Healthcare has announced the FDA approval of Cabenuva (cabotegravir, rilpivirine) for every-two-month dosing for
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025